| Financial Year |
March 31 2022 |
| Monetary Funds |
1,336,142,485.00 |
| Held-for-trading Financial Assets |
99,769,222.30 |
| Notes Receivable |
420,843,966.74 |
| Accounts Receivable |
564,426,697.59 |
| Advances to Suppliers |
81,648,616.06 |
| Other Receivables |
464,140,633.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,565,127,604.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,146,200.71 |
| Total Current Assets |
4,590,189,145.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
101,673,095.70 |
| Investment Properties |
-- |
| Fixed Assetes |
1,731,152,333.64 |
| Under-construction Projects |
391,984,535.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
168,944,282.05 |
| R&D expenses |
-- |
| Goodwill |
9,597,262.70 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
31,712,411.39 |
| Other Non-Current Assets |
78,381,013.55 |
| Sub-Total of Non-Current Assets |
2,526,654,671.16 |
| Total Assets |
7,116,843,816.46 |
| Short-Term Loans |
130,600,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,608,282,418.97 |
| Accounts Payable |
283,388,293.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,502,008.43 |
| Taxes Payable |
7,203,921.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
55,323,185.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
278,620,033.75 |
| Sub-Total of Current Liabilities |
2,450,954,908.15 |
| Long-term Loans |
137,378,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
37,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,255,762.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
210,633,762.42 |
| Total Liabilities |
2,661,588,670.57 |
| Paid-In Capital(Or Share Stock) |
907,053,586.00 |
| Capital Surplus |
1,220,670,099.37 |
| Surplus Reserve |
434,752,622.61 |
| LESS:Treasury Stock |
61,941,641.47 |
| Undistributed Profits |
1,754,981,063.71 |
| Minority Stockholder's Interest |
169,511,460.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,285,743,685.67 |
| Owner's Equity（Stockholder's Equity） |
4,455,255,145.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,116,843,816.46 |
